Welcome!

News Feed Item

DNA Sequencing: Emerging Technologies and Applications

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

DNA Sequencing: Emerging Technologies and Applications

http://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/dna_sequencing_emerging_technologies_applications.html

REPORT HIGHLIGHTS

The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

This report provides:
An overview of the global market for sequencing products and services.
Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
Quantification of the DNA sequencing markets by product type, platform, customer type,value chain position, analysis type and geography.
A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.

STUDY GOALS AND OBJECTIVES

BCC Research's goal for this study is to provide an in-depth analysis of the sequencing industry, an important industry in life sciences with enormous market potential. The approach for analyzing the industry is taken in terms of workflow (e.g., sequencers, sequence capture, informatics) and key applications (e.g., research, applied, services, sample prep, informatics) where sequencing will have market share by 2018.BCC Research examines the markets for sequencing products and services for the years 2012, 2013 and 2018.Special emphasis is placed on the global next-generation sequencing (NGS) diagnostic markets, which are characterized and quantified by disease indication, test complexity, test purpose and geography.Sequencing market segments that provide exciting growth opportunities include benchtop NGS sequencing instruments and consumables; clinical diagnostics (e.g., cancer, rare genetic diseases and prenatal screening); sequencing software; and consumer sequencing services.The report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for accessing sequencing industry opportunities.

REASONS FOR DOING THE STUDY

The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome.The HGP led to significant improvements in the efficiency and costs of DNA sequencing. During this time period, the sequencing industry consolidated, resulting in one dominant company, Applied Biosystems (now Life Technologies).Beginning in 2005, the launch of next-generation sequencing technologies radically changed the structure of the industry and opened up exciting new market applications. The costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests.As a result, opportunities for sequencing products and services are emerging in diverse applications ranging, for example, from clinical diagnostics to direct to consumer genetic testing markets.Clinical value has been shown for many applications, and several launched tests are having good commercial success. This shows that both patients and physicians are recognizing the value of NGS tests. Several molecular genetic tests that have been successful on non-NGS formats will run on NGS platforms in the future.At the same time, payors and insurance companies are beginning to provide coverage for these tests, further enhancing their commercial potential.In direct to consumer genetic testing market, there is an emerging trend to move to sequencing of specific genome regions. Compared with microarrays, sequencing provides more comprehensive information to the consumer. Recent product introductions by Full Genomes Corporation and Family Tree DNA using NGS to sequence the full Y chromosome are examples of this trend.These technical and market factors are driving this market so that it is now timely to examine the sequencing markets.

INTENDED AUDIENCE

This report fills a gap in market research as it covers the three main sequencing platforms: Sanger sequencing, NGS and 3GS.The report provides a roadmap for understanding where sequencing is likely to be used in the life sciences during the next five years. As such, it is a useful guide for strategic and business planning, as well as for learning about the impact new sequencing technologies will have in the various market segments.This market report will be useful to many companies involved in the direct to consumer, informatics, clinical, genetic testing and sequencing industries. It will be particularly valuable for companies in such industries as life science research tools, NGS instruments, molecular diagnostics, informatics, clinical laboratories, pharmaceutical, biotechnology, microfluidics, lab-on-a-chip and sample preparation.

SCOPE AND FORMAT

The scope of the report includes sequencing technologies, applications, industries, initiatives, markets, patents and companies. The markets for sequencing products and services are given for the years 2012, 2013 and 2018.This report reviews the main sequencing platforms, and explains why genetic variation is important for many markets, including clinical testing. It then discusses some of the top research initiatives that are contributing to NGS applications. Market driving forces are also discussed.The report covers the sequencing markets by workflow, including sample preparation products; sequencing instruments & consumables; informatics; and sequencing services. It includes the sequencing instrument market by platform: Sanger, NGS and 3GS and by instrument class: low throughput, high-throughput, benchtop, and handheld.The report covers the markets for the main sequencing end use applications, including research (R&D, drug discovery & development, biotech); clinical; consumer; and applied (forensics, microbial genomics, agricultural genomics).A key part of the report covers NGS clinical markets in depth, including by test complexity, indication and test purpose. Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics) will be in demand in the future.The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, rare diseases, common diseases, and pre- and post-natal screening.Specific geographic markets are discussed, including North America, Europe, China, Japan and the rest of the world.Market data covers the years 2012, 2013 and 2018.Industry sectors analyzed in this report include NGS instruments (including market share data for the main instrument companies); NGS target enrichment; 3GS; direct to consumer genetic testing; single cell genomics; NGS-based proteomics; informatics; information technology; clinical laboratory; and the prenatal diagnostics (including market shares for the leading NGS companies).More than 142 companies in the sequencing industry are profiled in this report.BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2011 through 2013, including key alliance trends.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC Research examined each of the key end-user market segments that will be commercially important during the next five years.Based on this analysis, the current and future applications of sequencing technologies are evaluated in each of the major market segments and sales revenues are forecast for 2013 through 2018.Based on analysis of both secondary and primary market sources, as well as the key trends in the industry, the report provides the current and projected market size for the various sequencing market segments for the years 2012, 2013 and 2018.
Chapter- 1: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST CREDENTIALS
BCC RESEARCH ONLINE SERVICES
DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY
Table Summary : GLOBAL VALUE OF SEQUENCING PRODUCTS AND SERVICES, BY TYPE, THROUGH 2018
Figure Summary : GLOBAL VALUE OF SEQUENCING PRODUCTS AND SERVICES, BY TYPE, 2012–2018
Chapter- 3: OVERVIEW
INTRODUCTION
SEQUENCING MARKET
SEQUENCING PRODUCTS
SEQUENCING PRODUCT LIFE CYCLE STATUS
NEXT-GENERATION SEQUENCING INDUSTRY
Chapter- 4: TECHNOLOGIES
IMPORTANCE OF DNA
GENETIC VARIATION AND ANALYSIS
GENETIC ANALYSIS TECHNOLOGIES
SEQUENCING IN CLINICAL APPLICATIONS
SEQUENCING TECHNOLOGIES
INFORMATICS TECHNOLOGIES
CLINICAL SEQUENCING TECHNOLOGY CHALLENGES
TOP TEN CLINICAL NEXT-GENERATION SEQUENCING INITIATIVES
Chapter- 5: DNA SEQUENCING APPLICATIONS
INTRODUCTION
GENETIC ANALYSIS
DE NOVO WHOLE GENOME SEQUENCING
RESEQUENCING
SEQ-BASED METHODS
STRUCTURAL VARIATION STUDIES
COMPLEMENTARY SEQUENCING AND MICROARRAY PLATFORMS
SEQUENCING END-USE APPLICATIONS
Chapter- 6: CLINICAL NEXT-GENERATION SEQUENCING APPLICATIONS
INTRODUCTION
CANCER APPLICATIONS
MENDELIAN DISORDERS APPLICATIONS
SCREENING APPLICATIONS
INFECTIOUS DISEASE APPLICATIONS
COMMON DISORDERS APPLICATIONS
Chapter- 7: SEQUENCING INDUSTRY
INTRODUCTION
NEXT-GENERATION SEQUENCING INSTRUMENT INDUSTRY
NEXT-GENERATION SEQUENCING TARGET ENRICHMENT INDUSTRY
THIRD GENERATION SEQUENCING INDUSTRY
DIRECT-TO-CONSUMER GENETIC TESTING INDUSTRY
SINGLE CELL GENOMICS INDUSTRY
NGS-BASED PROTEOMICS INDUSTRY
SEQUENCING INFORMATICS INDUSTRY
SEQUENCING INFORMATION TECHNOLOGY INDUSTRY
CLINICAL LABORATORY INDUSTRY
PRENATAL DIAGNOSTICS INDUSTRY
SEQUENCING INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
Chapter- 8: SEQUENCING MARKETS
GROWTH DRIVING FORCES
SEQUENCING MARKET SUMMARY
SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET
SEQUENCING SAMPLE PREP MARKETS
SEQUENCING INFORMATICS MARKET
SEQUENCING SERVICES MARKETS
CLINICAL NGS MARKET
CLINICAL NGS CANCER MARKETS
CLINICAL NGS CARDIOVASCULAR MARKETS
CLINICAL NGS MENDELIAN DISORDERS MARKETS
CLINICAL NGS METABOLIC AND IMMUNE DISORDERS MARKETS
CLINICAL NGS NEUROLOGY MARKETS
CLINICAL NGS NEWBORN SCREENING MARKETS
CLINICAL NGS PRENATAL DIAGNOSTIC MARKETS
CLINICAL NGS FOOD-BORNE ILLNESS MARKETS
CLINICAL NGS HUMAN LEUKOCYTE ANTIGEN TYPING MARKETS
SEQUENCING MARKETS BY GEOGRAPHIC REGION
CLINICAL NGS GEOGRAPHICAL MARKETS
Chapter- 9: CLINICAL NGS PATENTS
CLINICAL NEXT-GENERATION SEQUENCING PATENTS BY INDICATION
CLINICAL NEXT-GENERATION SEQUENCING PATENT ISSUES
Table 127 : CLINICAL NEXT-GENERATION SEQUENCING PATENTS*, 2002-2012
Chapter- 10: COMPANY PROFILES
23ANDME INC.
ADAPTIVE BIOTECHNOLOGIES INC.
AGILENT TECHNOLOGIES INC.
ALMAC GROUP LTD.
AMBRY GENETICS
APPISTRY INC.
ASSURERX HEALTH
ASTRID BIOSCIENCE GMBH
ASURAGEN INC.
AVIIR INC.
BASE4 INNOVATION LTD.
BECKMAN COULTER
BERRY GENOMICS CO. LTD.
BGI
BINA TECHNOLOGIES INC.
BLUEPRINT GENETICS
BOREAL GENOMICS
CAMBRIDGE EPIGENETIX LTD.
CARIS LIFE SCIENCES
CEGAT GMBH
CHRONIX BIOMEDICAL
CLC BIO
CODIFIED GENOMICS LLC
CORIELL LIFE SCIENCES INC.
CORRELAGEN DIAGNOSTICS INC
COUNSYL INC
COURTAGEN LIFE SCIENCES INC
CYNVENIO BIOSYSTEMS INC
CYPHER GENOMICS INC.
DIOGENIX INC.
DNA ELECTRONICS LTD.
DNA LINK
DNANEXUS INC.
EAGLE GENOMICS, LTD.
ELECTRONIC BIOSCIENCES
ENZYMATICS INC.
EUROFINS MWG OPERON
EXIQON A/S
EXOSOME DIAGNOSTICS INC.
EXPRESSION ANALYSIS INC.
FOUNDATION MEDICINE
FULL GENOMES CORPORATION
GATC BIOTECH AG
GE HEALTHCARE
GENAPSYS
GENDX BV
GENE BY GENE LTD.
GENEDX INC.
GENEPEEKS INC.
GENEWIZ INC.
GENIA TECHNOLOGIES INC.
GENOLOGICS LIFE SCIENCES SOFTWARE
GENOMATIX SOFTWARE GMBH
GENOMEQUEST INC.
GENOMIC HEALTH INC.
GIGAGEN INC.
GNUBIO INC.
GOOD START GENETICS INC.
ILLUMINA INC.
INGENUITY SYSTEMS INC.
INNOVATIONS EXCHANGE PTE LTD
INVITAE, INC.
IREPERTOIRE
KAILOS GENETICS
KELLBENX INC.
KNOME INC.
LABORATORY CORPORATION OF AMERICA INC.
LABORATORY FOR MOLECULAR MEDICINE
LASERGEN INC.
LIFE TECHNOLOGIES INC.
MACROGEN INC.
MAVERIX BIOMICS INC.
MD ANDERSON CANCER CENTER
MEDGENOME LABS PVT. LTD.
MEDOMICS LLC.
MIINOME INC.
MULTIPLICOM NV
MYRIAD GENETICS INC.
NABSYS INC.
NATERA INC.
NEWGENE LTD.
NOBLEGEN BIOSCIENCES
N-OF-ONE INC.
NOVARTIS AG
NUMERATE INC.
NXT-DX
OMICIA INC.
OMIXON BIOCOMPUTING KFT
ONCODNA SA
ONCOSPIRE GENOMICS
OXFORD GENE TECHNOLOGY
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PARABASE GENOMICS
PASTEL BIOSCIENCE LTD
PATHOGENETIX
PATHOGENICA
PATHOQUEST SAS
PERKIN ELMER INC.
PERSONAL GENOME DIAGNOSTICS INC.
PERSONALIS INC.
PICOSEQ
POPULATION GENETICS TECHNOLOGIES LTD.
PORTABLE GENOMICS LLC
PREVENTIONGENETICS INC.
QIAGEN
QUANTUMDX
RAINDANCE TECHNOLOGIES INC.
REAL TIME GENOMICS INC.
REPROGENETICS
RESPONSE GENETICS INC.
ROCHE HOLDING AG
SCIGENOM LABS
SENGENICS INTERNATIONAL PTE LTD.
SEQUENOM INC.
SEQUENTA INC.
SEQUOIA GENETICS CO. LTD.
SEVEN BRIDGES GENOMICS INC.
SIEMENS AG
SILICON VALLEY BIOSYSTEMS
SINGLE CELL TECHNOLOGY, INC.
SISTEMAS GENOMICOS
SOFTGENETICS LLC
SPIRAL GENETICS INC.
STATION X INC.
STRAND LIFE SCIENCES
STRATOS GENOMICS INC.
SUNDANCE DIAGNOSTICS INC.
SYAPSE
SYGNIS AG
SYNAPDX
THERMO FISHER SCIENTIFIC INC.
TRANSGENOMIC INC.
TROVAGENE INC.
TUTE GENOMICS, INC.
TWO PORE GUYS INC.
WARP DRIVE BIO LLC
YIKON GENOMICS CO. LTD.
ZS GENETICS
ZYMO RESEARCH CORPORATION

Read the full report:
DNA Sequencing: Emerging Technologies and Applications

http://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/dna_sequencing_emerging_technologies_applications.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will d...
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
When building large, cloud-based applications that operate at a high scale, it's important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. "Fly two mistakes high" is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Le...
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
CI/CD is conceptually straightforward, yet often technically intricate to implement since it requires time and opportunities to develop intimate understanding on not only DevOps processes and operations, but likely product integrations with multiple platforms. This session intends to bridge the gap by offering an intense learning experience while witnessing the processes and operations to build from zero to a simple, yet functional CI/CD pipeline integrated with Jenkins, Github, Docker and Azure...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Dhiraj Sehgal works in Delphix's product and solution organization. His focus has been DevOps, DataOps, private cloud and datacenters customers, technologies and products. He has wealth of experience in cloud focused and virtualized technologies ranging from compute, networking to storage. He has spoken at Cloud Expo for last 3 years now in New York and Santa Clara.
Enterprises are striving to become digital businesses for differentiated innovation and customer-centricity. Traditionally, they focused on digitizing processes and paper workflow. To be a disruptor and compete against new players, they need to gain insight into business data and innovate at scale. Cloud and cognitive technologies can help them leverage hidden data in SAP/ERP systems to fuel their businesses to accelerate digital transformation success.
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.